Literature DB >> 10336141

Loss of olfactory function in dementing disease.

C Murphy1.   

Abstract

Alzheimer's (AD) patients show neuropathological changes in areas of the brain central to olfactory processing, suggesting the theoretical importance and potential diagnostic utility of investigating functional changes in olfaction in these patients. Persons with Down's Syndrome who live to the fourth decade develop neuropathological changes in the brain similar to those found in AD. A series of investigations have been conducted to assess olfaction function in both patients with Alzheimer's disease and persons with Down's Syndrome. Functional testing included olfactory threshold, odor identification, odor similarity judgements, odor recognition memory, odor recall, odor fluency. Both Alzheimer's patients and persons with Down's Syndrome showed significant impairment in olfactory function, with some measures showing more impairment than others in the early stages of the disease process. Longitudinal investigation of several of the measures indicated decreased function over time consonant with falling DRS scores. Normal controls who tested positive for the APOE4 allele showed impaired odor identification compared to those who were allele negative. Patients with Huntington's Disease showed olfactory functional impairments, although the degree of impairment differed from the cortical dementias for some of these tasks. The sensitivity and specificity of these assessments will be discussed in relation to analogous assessments in other sensory modalities.

Entities:  

Mesh:

Year:  1999        PMID: 10336141     DOI: 10.1016/s0031-9384(98)00262-5

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  40 in total

1.  Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration.

Authors:  D Frenkel; O Katz; B Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  Sensory network dysfunction, behavioral impairments, and their reversibility in an Alzheimer's β-amyloidosis mouse model.

Authors:  Daniel W Wesson; Anne H Borkowski; Gary E Landreth; Ralph A Nixon; Efrat Levy; Donald A Wilson
Journal:  J Neurosci       Date:  2011-11-02       Impact factor: 6.167

3.  Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer's disease mouse model.

Authors:  Jose Morales-Corraliza; Stephen D Schmidt; Matthew J Mazzella; Jason D Berger; Donald A Wilson; Daniel W Wesson; Mathias Jucker; Efrat Levy; Ralph A Nixon; Paul M Mathews
Journal:  Neurobiol Aging       Date:  2012-05-18       Impact factor: 4.673

4.  Should olfactory dysfunction be used as a biomarker of Alzheimer's disease?

Authors:  Daniel W Wesson; Donald A Wilson; Ralph A Nixon
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

5.  Semantic networks for odors and colors in Alzheimer's disease.

Authors:  Jill Razani; Agnes Chan; Steven Nordin; Claire Murphy
Journal:  Neuropsychology       Date:  2010-05       Impact factor: 3.295

Review 6.  Mechanisms of neural and behavioral dysfunction in Alzheimer's disease.

Authors:  Daniel W Wesson; Ralph A Nixon; Efrat Levy; Donald A Wilson
Journal:  Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.590

7.  The association between smoking and smell and taste impairment in the general population.

Authors:  Mechtild M Vennemann; Thomas Hummel; Klaus Berger
Journal:  J Neurol       Date:  2008-07-28       Impact factor: 4.849

8.  Lateral entorhinal modulation of piriform cortical activity and fine odor discrimination.

Authors:  Julie Chapuis; Yaniv Cohen; Xiaobin He; Zhijan Zhang; Sen Jin; Fuqiang Xu; Donald A Wilson
Journal:  J Neurosci       Date:  2013-08-14       Impact factor: 6.167

Review 9.  Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  J Neural Transm (Vienna)       Date:  2015-05-06       Impact factor: 3.575

10.  Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults.

Authors:  Carla R Schubert; Lakeesha L Carmichael; Claire Murphy; Barbara E K Klein; Ronald Klein; Karen J Cruickshanks
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.